Viewing Study NCT06475235


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2025-12-30 @ 3:22 PM
Study NCT ID: NCT06475235
Status: RECRUITING
Last Update Posted: 2025-07-24
First Post: 2024-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module